NCT02948764 - Diagnosis of Pathological Complete Response by Vacuum-assisted Biopsy After Neoadjuvant Chemotherapy in Breast Cancer | Biotech Hunter

Enrollment

452

Participants

Timeline

Start Date

March 8, 2017

Primary Completion Date

May 24, 2019

Study Completion Date

September 15, 2019

Conditions

Breast Neoplasms

Interventions

DEVICE

Vacuum-Assisted Biopsy

The vacuum-assisted (7-10G), minimal invasive biopsy (VAB), either guided by ultrasound, or by mammography (stereotaxy) during the second trial visit (V2) will be performed once. In analogy to the German S3 guideline on primary breast cancer management we recommend to take at least 12 biopsies with 10G needles or less in case of larger needle sizes.

Trial Locations (1)

69120

University Breast Unit, Department of Gynecology, University of Heidelberg, Heidelberg